latest news in companies
Global Power Solutions Explores 100-Megawatt Modular Hydrogen Project
Vancouver, Monday, 27 April 2026.
Global Power Solutions is evaluating a 100-megawatt modular hydrogen project, marking a strategic corporate pivot from traditional steel manufacturing into the decentralized, sustainable clean energy sector.
Kontent.ai Appoints Mark Greenaway to Lead AI-Driven Content Management Expansion
New York, Monday, 27 April 2026.
Newly appointed CEO Mark Greenaway will scale Kontent.ai’s AI platform to solve enterprise bottlenecks, cutting manual workflows by 70 percent and delivering an impressive 320 percent ROI.
SoftBank and TOPPAN Pioneer Ultra-Durable Wing Material for Stratospheric Solar Aircraft
Tokyo, Monday, 27 April 2026.
SoftBank and TOPPAN have developed an innovative wing skin capable of withstanding near -100°C temperatures, paving the way for long-endurance stratospheric aircraft to bridge global telecommunication gaps by 2029.
FDA Grants Exclusive Market Status to OSE Immunotherapeutics for Heart Transplant Drug
Nantes, Monday, 27 April 2026.
The FDA has granted OSE Immunotherapeutics lucrative Orphan Drug Designation for its heart transplant treatment, unlocking seven years of potential market exclusivity and significant developmental tax incentives.
Novartis Secures Landmark European Approval for New Oral Skin Therapy
Basel, Monday, 27 April 2026.
Novartis secured European approval for Rhapsido, the first oral targeted therapy for chronic hives. Requiring no liver monitoring, this breakthrough safely unlocks a highly lucrative market for investors.
European Regulators Back Santhera's Expanded Muscular Dystrophy Treatment for Toddlers
Pratteln, Monday, 27 April 2026.
European regulators recommended expanding Santhera’s muscular dystrophy drug to children aged two and older. Notably, the therapy yields an 80% reduction in vertebral fractures compared to traditional treatments.
